Results 161 to 170 of about 1,377 (250)

The Futures of Digital Democracy: Four Scenarios. [PDF]

Open Res Eur
Fuchs C, Museba J, Friesch K.
europepmc   +1 more source

Developing a critical caste analysis within information science and technology: A research review: An Annual Review of Information Science and Technology (ARIST) paper

Journal of the Association for Information Science and Technology, EarlyView.
Abstract Caste—an ascriptive social hierarchy in South Asia and its diaspora—is a globalized phenomenon. Recent caste‐based discrimination, particularly in technology companies and anti‐caste efforts to address it, has compelled academia, policy, and the technology industry to better understand contemporary mechanics of caste.
Nayana Kirasur, Britt Paris
wiley   +1 more source

Carbon pricing drives critical transition to green growth. [PDF]

Nat Commun
Mengesha I, Roy D, Roy D.
europepmc   +1 more source

The hare and the tortoise: Open access publications' immediate impact and lasting advantage

Journal of the Association for Information Science and Technology, EarlyView.
Abstract Open Access has changed how research is published and discovered. Studies generally report that OA articles are cited and mentioned more often than non‐OA, describing an open access advantage (OAA). The mechanisms causing the OAA are under‐investigated: this research analyzes citation and altmetrics post‐publication, reporting on the ...
Michael Taylor
wiley   +1 more source

Comparative Analysis of Plastic Waste Management Options Sustainability Profiles. [PDF]

Polymers (Basel)
Enache MM, Gavrilescu D, Teodosiu C.
europepmc   +1 more source

Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapy

British Journal of Clinical Pharmacology, EarlyView.
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden, Miriam G. Mooij, Matthijs de Hoog, Saskia N. de Wildt   +3 more
wiley   +1 more source

The Political Determinants of Oral Health Inequalities: Lessons in Policy Development and Implementation From Six Case Studies. [PDF]

Community Dent Oral Epidemiol
Serban ST, Perdomo S, Borges-Yañez A, Allen F, Guarnizo-Herreño C, Navarro-Ramírez MK, Hobbs M, Cohen LK, Tsakos G, Baker SR, Conway DI.   +10 more
europepmc   +1 more source

Financial Risk Management of the Russian Economy During the COVID-19 Pandemic

, 2023
Kolchin SP, Glubokova NY, Gordienko MS, Semenova GN, Khalilova MK.   +4 more
europepmc   +1 more source

Utilization of immune checkpoint inhibitors for the treatment of cancer in Scotland, 2018–2024: A national retrospective cohort study

British Journal of Clinical Pharmacology, EarlyView.
Aims The aim of the study is to describe the use of immune checkpoint inhibitors (ICIs) for the treatment of cancer in Scotland. Methods The retrospective observational cohort study included patients aged 18 years or older who commenced treatment with an ICI in Scotland between 1 January 2018 and 31 December 2024.
Tanja Mueller, Christine Crearie, Liya Lu, Jiafeng Pan, Fraser N. Sneden, David Martin, Amanj Kurdi, Catherine S. Thomson, Julie Clarke, Marion Bennie   +9 more
wiley   +1 more source

The distribution of power and inclusiveness across deep time. [PDF]

Sci Adv
Feinman GM, Stasavage D, Carballo DM, Barber SB, Green A, Holland-Lulewicz J, Lawrence D, Munson J, Nicholas LM, Fulminante F, Klassen S, Kintigh KW, Douglass J.   +12 more
europepmc   +1 more source